Evidence map›Paper›PMID 39152680›Full record

ReviewClinical and translational medicine2024

Liver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations.

Qi Liu, Senyan Wang, Jing Fu, Yao Chen, Jing Xu, Wenjuan Wei, Hao Song, Xiaofang Zhao, Hongyang Wang

Abstract readReview
In one paragraph

Review in Clinical and translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A Comprehensive Understanding ofCurrent issues in molecular biology · 2026
    Review
  3. Review
  4. Article
  5. Kupffer cells: Orchestrators of liver physiology.Liver research (Beijing, China) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. 6-Antioxidants (Basel, Switzerland) · 2025
    Article
  15. Article
  16. Review
  17. Review
  18. Acta biochimica et biophysica Sinica · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qi LiuTranslational Medicine Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Senyan WangTranslational Medicine Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Jing FuInternational Cooperation Laboratory on Signal Transduction, National Center for Liver Cancer, Ministry of Education Key Laboratory on Signaling Regulation and Targeting Therapy of Liver Cancer, Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/NAVAL Medical University, Shanghai, China.
Yao ChenInternational Cooperation Laboratory on Signal Transduction, National Center for Liver Cancer, Ministry of Education Key Laboratory on Signaling Regulation and Targeting Therapy of Liver Cancer, Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/NAVAL Medical University, Shanghai, China.
Jing XuTranslational Medicine Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Wenjuan WeiTranslational Medicine Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Hao SongTranslational Medicine Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Xiaofang ZhaoTranslational Medicine Centre, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Hongyang WangInternational Cooperation Laboratory on Signal Transduction, National Center for Liver Cancer, Ministry of Education Key Laboratory on Signaling Regulation and Targeting Therapy of Liver Cancer, Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University/NAVAL Medical University, Shanghai, China.ORCID 0000-0002-4709-3334

Funding

National Key Research and Development Program of China 2022YFC3400902National Natural Science Foundation of China 82073411Natural Science Foundation of Henan Province 242300420070the Open Project of Key Laboratory of the Ministry of Education 2022-MEKLLC-ZD-002
6 · The paper itself

Abstract

The liver possesses a distinctive capacity for regeneration within the human body. Under normal circumstances, liver cells replicate themselves to maintain liver function. Compensatory replication of healthy hepatocytes is sufficient for the regeneration after acute liver injuries. In the late stage of chronic liver damage, a large number of hepatocytes die and hepatocyte replication is blocked. Liver regeneration has more complex mechanisms, such as the transdifferentiation between cell types or hepatic progenitor cells mediated. Dysregulation of liver regeneration causes severe chronic liver disease. Gaining a more comprehensive understanding of liver regeneration mechanisms would facilitate the advancement of efficient therapeutic approaches. This review provides an overview of the signalling pathways linked to different aspects of liver regeneration in various liver diseases. Moreover, new knowledge on cellular interactions during the regenerative process is also presented. Finally, this paper explores the potential applications of new technologies, such as nanotechnology, stem cell transplantation and organoids, in liver regeneration after injury, offering fresh perspectives on treating liver disease.

Indexed as

Liver RegenerationAnimalsCell CommunicationHepatocytesHumansLiverLiver DiseasesSignal Transductioninterventionsliver injury modelliver regenerationsignalling pathway

Identifiers

PMID39152680
PMCPMC11329751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.